Resolution Therapeutics

Resolution Therapeutics is a clinical stage biotech company pioneering macrophage cell therapy for the treatment of end stage liver disease.

[Resolution Therapeutics @ResolutionTx]

@ResolutionTx will be in San Francisco next month for JPM Week 2026, taking place from January 12-15.

Reach out to connect and set up a meeting with the team.

#JPM2026 #macrophages #drugdevelopment

[Resolution Therapeutics @ResolutionTx]

After another successful #AASLD, we look ahead to next week when our team will be heading to London for Jefferies and London Life Sciences Week.
Our CFO Lucy Singah and VP Strategy & Operations Victor Dillard will be there – reach out to set up a meeting!

[Resolution Therapeutics @ResolutionTx]

We are thrilled to announce new clinical and preclinical data to be presented at the @AASLDtweets The Liver Meeting® 2025

The data strongly supports the hypothesis that RMT has anti-inflammatory and anti-fibrotic effects in cirrhosis.

Full PR here: https://t.co/Yponcg3BN8

[Resolution Therapeutics @ResolutionTx]

We are proud to share that @ResolutionTx has been named a finalist in two categories at the 2025 @lifestarsawards! ⭐

Our CEO Amir Hefni has been shortlisted for CEO of the Year, while Resolution is a finalist for ‘Series B Raise of the Year’!

#OneTeam #LifestarsAwards

[Resolution Therapeutics @ResolutionTx]

We are pleased to announce that @ResolutionTx has had two abstracts selected for presentation at the @AASLDtweets ‘The Liver Meeting’ in Washington D.C., from the 7 - 11 November.

For full details, see the press release here: https://t.co/zF6Vo56i4n

[Resolution Therapeutics @ResolutionTx]

This week, @ResolutionTx will be attending and presenting at the BASL annual meeting 2025 in Belfast, Northern Ireland.

Professor @JAFallowfield, will present a poster detailing the study protocol for the Phase I/II EMERALD study of RTX001.
Press release: https://t.co/y5mS3Ze1nb

[Resolution Therapeutics @ResolutionTx]

At @ResolutionTx, we 've got a busy start to the conference season!

Our team members will be attending and presenting at multiple conferences in October.

Visit our LinkedIn for more details and do get in touch to connect at these events: https://t.co/HI1ZxFKIrR

[Federación Española del Hígado - FEH @fehigado]

👉 En Resolution Therapeutics trabajan con macrófagos para tratar a pacientes en riesgo de descompensación hepática

Más en nuestra web ⤵️

https://t.co/vc2CCbRon1

🤝 Una colaboración de FNETH y @ResolutionTx 

#FNETH #ResolutionTherapeutics #Health #ClinicalTrial

[Resolution Therapeutics @ResolutionTx]

This week @ResolutionTx unveiled our EMERALD HEROES TILE to our wall of pride in both our London and Edinburgh offices.

This celebrates the dosing of the first patient in the Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease.

#OneTeam

[Resolution Therapeutics @ResolutionTx]

We are about to go LIVE!

Join us TODAY at 14.00 BST for a virtual R&D webinar discussing our regenerative macrophage therapies to treat inflammatory and fibrotic diseases with world leading hepatologists @JAFallowfield and @ebtapper

Register here: https://t.co/ZGETQxEmjl

[Resolution Therapeutics @ResolutionTx]

🎥Don’t miss our virtual R&D webinar TOMORROW at 14:00 BST with world leading hepatologists @JAFallowfield and @ebtapper

This webinar will be a fantastic opportunity to explore the current treatment landscape for end-stage liver disease.

Register here: https://t.co/ZGETQxEmjl

[Resolution Therapeutics @ResolutionTx]

🎥 Join us on Wednesday at 14.00 BST for a virtual R&D webinar!

Hear from our senior leadership team, alongside chief Investigator of the Phase 1/2 EMERALD study, @JAFallowfield , and esteemed hepatologist, @ebtapper.

Register here: https://t.co/dSVbCvslde

[Resolution Therapeutics @ResolutionTx]

📢 Don't miss @ResolutionTx's virtual R&D webinar next Wednesday!

Join to hear presentations from the senior leadership team and world leading clinical hepatologists @ebtapper and @JAFallowfield.

Register for the webinar here: https://t.co/dSVbCvrNnG

[Resolution Therapeutics @ResolutionTx]

Today @ResolutionTx is pleased to announce the appointment of Lucy Singah as CFO and Daniel Kennedy as CBO.

Lucy joins to drive corporate and strategic goals, and Daniel will drive business development and partnering deals.

#appointment #CFO #CBO #ONETEAM

[Resolution Therapeutics @ResolutionTx]

@ResolutionTx announces today that the first patient has been dosed and safety cleared in its Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease.

The study is now open for full enrolment in the UK and Spain

Read the press release below.

[Resolution Therapeutics @ResolutionTx]

📢 @ResolutionTx to host virtual R&D webinar on 17 September at 14:00 BST alongside world leading clinical hepatologists @ebtapper and @JAFallowfield

Register here: https://t.co/DKj77WE8wK

Read the press release here: https://t.co/mziUpdkZIf

[Resolution Therapeutics @ResolutionTx]

@ResolutionTx VP Clinical Operations Esther Kitto will be in Munich, Germany this week from May 21-22 for the 19th Clinical Trials Strategic Summit!

Be sure to reach out to Esther to connect, and catch her presentation if you're also in Munich!

[Resolution Therapeutics @ResolutionTx]

@ResolutionTx has announced two data presentations at #ASGCT in New Orleans, US, May 13-17, 2025!

The team will deliver insights from a proprietary ex vivo RMT manufacturing process and a candidate testing suite.

Read more: https://t.co/zeW42K2Ap6

#ESLD #ASGCT2025 #CellTherapy

[Resolution Therapeutics @ResolutionTx]

Catch Victor Dillard, VP Strategy and Operations in Bruges for this year's Bio€quity Europe.

Victor will be delivering a company presentation, where you can learn more about our approach to pioneering regenerative macrophage therapy in inflammatory and fibrotic diseases.

[Resolution Therapeutics @ResolutionTx]

Next week marks the beginning of the @EASLnews Congress, this year being held in Amsterdam, The Netherlands, between May 7-10, 2025.

Reach out to the @ResolutionTx team who will be attending the conference!

#RMT #EASLCongress #liverdisease